Abstract
The care and study of children with rheumatic diseases began slowly in the 19th century, with the most attention centered on rheumatic fever. Other rheumatic diseases of children received little attention until the 1940s. Rheumatic diseases taken together remain a significant cause of chronic illness in children throughout the world. A number of other conditions that masquerade as rheumatic diseases in children also demand recognition and management. Although ultimate causes and cures of childhood rheumatic diseases remain elusive, advances in therapy have improved the outlook for affected children, and advances in biomedical research are adding to our basic understanding of the disease process involved. Pediatric rheumatology has become a well-organized, although underpopulated, specialty that enhances recognition and care of affected children and contributes to basic research knowledge in infectious disease, immunology, and genetics. This review focuses most prominently on the early history of pediatric rheumatology and its development as a specialty. The recent burgeoning of new biomedical science and new means of treatment will be better told in the historical perspective of years to come.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Bywaters EG 1977 The history of pediatric rheumatology. Arthritis Rheum 20: 145–152
Short CL, Bauer W, Reynolds WE 1957 Rheumatoid Arthritis. Harvard University Press, Cambridge, p 30
Still GF 1897 On a form of chronic joint disease in children. Medico-Chirurgical Trans 80: 47–59; reprinted in Am J Dis Child 1978;132:195–200
Goodhart JF, Still GF 1913 The Diseases of Children. J & A Churchill, London, p 777
Still GF 1931 The History of Paediatrics. Oxford University Press, London, p 503
Phaer T 1545 The Boke of Chyldren. London
Still GF 1910 Common Disorders and Diseases of Childhood. Oxford University Press, London
Stone E 1763 An account of the success of the bark of the willow in the cure of agues. Philos Trans R Soc Lond 53: 195–200
Schlesinger B 1930 The relationship of throat infection to acute rheumatism in childhood. Arch Dis Child 5: 411–430
Denny FW Jr, Wannamaker LW, Brink WR, Rammelkamp CH, Custer EA 1950 Prevention of rheumatic fever: treatment of the preceding streptococcal infection. JAMA 143: 151–153
Markowitz M, Gordis L 1972 Rheumatic Fever. WB Saunders, Philadelphia
Kaplan EL 1993 The T. Duckett Jones Memorial Lecture. Global assessment of rheumatic fever and rheumatic heartdisease at the close of the century. Influences and dynamics of population and pathogens: a failure to realize prevention?. Circulation 88: 1964–1972
WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease 2001 Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation. WHO Technical Report Series No. 923, World Health Organization, Geneva
Cornil MV 1864 [Report on the pathology of chronic articular rheumatism.] Compte rendu Med Soc Bio Series (Paris) 4: 3–6
Bouchet E 1875 [Practical treatise of illnesses in children.] JB Bailliere et fils, Paris
Garrod AB 1876 A Treatise on Gout and Rheumatic Gout. Longmans, Green & Company, London
Lewis-Smith JL 1876 A Treatise on Diseases of Infancy and Childhood. Henry C. Lea, Philadelphia
Moncorvo CA 1880 [Chronic rheumatism of children and its treatment.] O Doin, Paris
West C 1881 Lectures on the Diseases of Infancy and Childhood. Longman, Brown, Green and Longman, London
Garrod AE 1890 A Treatise on Rheumatism and Rheumatoid Arthritis. Griffin, London
Marfan AB 1896 [Treatise on Illnesses of Children.] Masson, Paris
Kuhns JG, Swaim LT 1932 Disturbances of growth in chronic arthritis in children. Am J Dis Child 43: 1118–1133
Ansell BM, Bywaters EG, Spencer PE, Tyler JP 1997 Looking Back 1947–1985: The Canadian Red Cross Memorial Hospital, Cliveden, Taplow, England. Barbara M. Ansell, Buckinghamshire
[Children's Clinic Garmish-Partenkirchen for children and youths.] (http://www.rheuma-kinderklinik.de/rpages/english/e_history.htm)
Colver T 1937 The prognosis in rheumatoid arthritis in childhood. Arch Dis Child pp 253–260
Coss JA, Boots RH 1946 Juvenile rheumatoid arthritis: a study of 56 cases with a note on skeletal changes. J Pediatr 29: 143–156
Schlesinger B 1949 Rheumatoid arthritis in the young. Brit Med J July: 197–201
Barkin RE 1952 The clinical course of juvenile rheumatoid arthritis. Bull Rheum Dis 3: 19–20
Sury B 1952 Rheumatoid Arthritis in Children: A Clinical Study. Andressen & Co, Copenhagen, Denmark
Gauchat RD, May CD 1957 Early recognition of rheumatoid disease with comments on treatment. Pediatrics 19: 672–679
Edstrom G 1958 Rheumatoid arthritis and Still's disease in children: a survey of 161 cases. Arthritis Rheum 1: 497–504
Grokoest AW, Snyder AI, Ragan C 1957 Some aspects of juvenile rheumatoid arthritis. Bull Rheum Dis 8: 147–148
Norcross BM, Lockie LM, MacLeod CC 1958 Juvenile rheumatoid arthritis. In: Ralbott JH, Lockie LM (eds) Progress in Arthritis. Grune & Stratton, New York, pp 57–85
Sairanen E 1958 On rheumatoid arthritis in children. Acta Rheum Scand 4: 1–79
Ansell BM, Bywaters EG 1959 Prognosis in Still's disease. Bull Rheum Dis 9: 189–192
Jacobs P 1963 Ankylosing spondylitis in children and adolescents. Arch Dis Child 38: 492–499
Schaller J, Bitnum S, Wedgwood RJ 1969 Ankylosing spondylitis with childhood onset. J Pediatr 74: 505–516
Ladd JR, Cassidy JT, Martel W 1971 Juvenile ankylosing spondylitis. Arthritis Rheum 14: 579–590
Talbot JH 1974 Historical background of discoid and systemic lupus In: Dubois EL (ed) Lupus Erythematosus, 2nd Ed. University of Southern California Press, Los Angeles, pp 1–11
Hargraves MM, Richmond H, Morton R 1948 Presentation of two bone marrow elements, the “tart” cell and the “LE” cell. Mayo Clin Proc 23: 25–28
Haserick JR, Lewis LA, Bortz DW 1950 Blood factor in acute disseminated lupus erythematosus. 1. Determination of gamma globulin as specific plasma fraction. Am J Med Sci 219: 660–663
Zetterstrom R, Berglund G 1956 Systemic lupus erythematosus in childhood; a clinical study. Acta Pediatri 45: 189–204
Gribetz D, Henley WL 1959 Systemic lupus erythematosus in childhood. J Mt Sinai Hosp N Y 26: 289–296
Cook CD, Wedgwood RJ, Craig JM, Hartmann JR, Janeway CA 1960 Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics 26: 570–585
Jacobs JC 1963 Systemic lupus erythematosus in childhood. Report of thirty-five cases, with discussion of seven apparently induced by anticonvulsant medication, and of prognosis and treatment. Pediatrics 32: 257–264
Peterson RD, Vernier RL, Good RA 1963 Lupus erythematosus. Pediatr Clin North Am 10: 941–978
Hagge WW, Burke EC, Stickler GB 1967 Treatment of systemic lupus erythematosus complicated by nephritis in children. Pediatrics 40: 822–827
Hanson V, Kornreich H 1967 Systemic rheumatic disorders (“collagen disease”) in childhood lupus erythematosus, anaphylactoid purpura, dermatomytositis, and scleroderma. II. Bull Rheum Dis 17: 441–446
Robinson MJ, Williams AL 1967 Systemic lupus erythematosus in childhood. Aust Pediatr J 3: 36–47
Meislin AG, Rothfield N 1968 Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics 42: 37–49
Wedgwood RJ, Cook CD, Cohen J 1953 Dermatomyositis. Report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics 12: 447–466
Pearson CM 1962 Polymyositis and dermatomyositis. Bull Rheum Dis 12: 269–272
Banker BQ, Victor M 1966 Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore) 45: 261–289
Sullivan DB, Cassidy JT, Petty RE, Burt A 1972 Prognosis in childhood dermatomyositis. J Pediatr 80: 555–563
Wedgwood RJ, Klaus MH 1955 Anaphylactoid purpura (Schonlein-Henoch syndrome): a long-term follow-up study with special reference to renal involvement. Pediatrics 16: 196–206
Bywaters EG, Isdale I, Kempton JJ 1957 Schonlein-Henoch purpura; evidence for a group A beta-haemolytic streptococci aetiology. Q J Med 26: 161–175
Allen DM, Diamond LK, Howell DA 1960 Anaphylactoid purpura in children (Schonlein-Henoch syndrome): review with a follow-up of the renal complications. Am J Dis Child 99: 833–854
Vernier RL, Worthen HG, Peterson RD, Colle E, Good RA 1961 Anaphylactoid purpura, pathology of the skin and kidney and frequency of streptococcal infection. Pediatrics 27: 181–193
Fager DB, Bigler JA, Simonds P 1951 Periarteritis nodosa in infancy and childhood. J Pediatr 39: 65–79
Munro-Faure H 1959 Necrotizing arteritis of the coronary vessels in infancy; case report and review of the literature. Pediatrics 23: 914–926
Roberts FB, Fetterman GH 1963 Polyarteritis nodosa in infancy. J Pediatr 63: 519–529
Kawasaki T 1967 [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children.] Arerugi 16: 178–222
Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H 1974 A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54: 271–276
Chazen EM, Cook CD, Cohen J 1962 Focal scleroderma. Report of 19 cases in children. J Pediatr 60: 385–393
Kass H, Hanson V, Patrick J 1966 Scleroderma in childhood. J Pediatr 68: 243–256
Winkelmann RK, Kierland RR, Perry HO, Muller SA, Sams WM 1971 Symposium on scleroderma. Mayo Clin Proc 46: 128–133
Brewer E, Bass JC, Cassidy JT, Duran BS, Fink BS, Fink CW, Jacobs JC, Markowitz MM, Reynolds WE, Schaller JG, Stillman JS, Wallace SL 1973 Criteria for the classification of juvenile rheumatoid arthritis. Bull Rheum Dis 23: 712–719
Levinson JE, Baum J, Brewer E Jr, Fink C, Hanson V, Schaller J 1977 Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. J Pediatr 91: 799–804
Schaller JG, Hanson V (eds) 1976 Proceedings of the First ARA Conference on the Rheumatic Diseases of Childhood Park City, Utah, March 22–25, 1976. Arthritis Rheum 20: 145–638
Wood PH 1978 Special meeting on nomenclature and classification of arthritis in children: proposed criteria for controlled clinical studies. Scand J Rheumatol 11: 187–192
Pediatric Rheumatology: Park City and Beyond, Snowmass, CO, 2003 1:3–5 www.pedrheumonlinejournal.org
American Board of Pediatrics (available at www.abp.org)
2000 The future status of pediatric rheumatology in the United States: strategic planning for the year 2000. American College of Rheumatology Blue Ribbon Committee for Academic Pediatric Rheumatology. Arthritis Rheum 43: 239–242
Cassidy JT, Athreya BH, Nelson AM, Lindsley CB 2003 The regional distribution of pediatric rheumatologists in medical schools in the United States–2002. Pediatr Rheumatol Online J (available at http://www.pedrheumonlinejournal.org/August/Pediatric%20Rheumatology/174.htm)
Malleson PN, Fung MY, Rosenberg AM 1996 The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J Rheumatol 23: 1981–1987
Sherry DD, Wallace CA, Kahn SJ 1996 Pediatric rheumatology in adult rheumatology practices in Washington State. Arthritis Rheum 39: 1218–1221
Mayer ML, Sandborg CI, Mellins ED 2004 Role of pediatric and internist rheumatologists in treating children with rheumatic diseases. Pediatrics 113: e173–e181
Stoddard JJ, Cull WL, Jewett EA, Brotherton SE, Mulvey HJ, Alden ER 2000 Providing pediatric subspecialty care: a workforce analysis. AAP Committee on Pediatric Workforce Subcommittee on Subspecialty Workforce. Pediatrics 106: 1325–1333
Hench PS, Kendall EC, Slocumb CH, Polley HF 1949 The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis: Preliminary report. Proc Staff Meet Mayo Clinic 24: 181–197
Giannini EH, Brewer EJ Jr 1982 Standard methodology for segment I, II and III Pediatric Rheumatology Collaborative Study Group studies. I. Design. J Rheumatol 9: 109–122
Brewer EJ, Giannini EH, Baum J, Cassidy JT, Fink CW, Hanson V, Levinson JE, Schaller JG 1982 Sodium meclofenamate (Meclomen) in the treatment of juvenile rheumatoid arthritis. A segment I study. J Rheumatol 9: 129–134
Brewer EJ, Giannini EH, Baum J, Fink CW, Hanson V, Jacobs JC, Schaller JG 1982 Proquazone (Biarsan) in the treatment of juvenile rheumatoid arthritis. A segment I study. J Rheumatol 9: 135–139
Bass JC, Giannini EH, Brewer EJ, Athreya B, Brandstrup NE, Goldsmith DP, Miller JJ, Pachman LM 1982 Pirprofen (Rengasil) in the treatment of juvenile rheumatoid arthritis. A segment I study. J Rheumatol 9: 140–143
Brewer EJ, Giannini EH, Baum J, Bernstein B, Fink CW, Schaller JG, Knee CM 1982 Ketoprofen (Orudis) in the treatment of juvenile rheumatoid arthritis. A segment I study. J Rheumatol 9: 144–148
Brewer EJ, Giannini EH, Baum J, Bernstein B, Fink CW, Emery HM, Schaller JG 1982 Aspirin and fenoprofen (Nalfon) in the treatment of juvenile rheumatoid arthritis results of the double blind-trial. A segment II study. J Rheumatol 9: 123–128
Giannini EH, Brewer EJ, Miller ML, Gibbas D, Passo MH, Hoyeraal HM, Bernstein B, Person DA, Fink CW, Alexander LA, Scheinbaum ML 1990 Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr 117: 645–652
Giannini EH, Brewer EJ, Kuzmina N, Alekseev L, Shokh BP 1988 Characteristics of responders and nonresponders to slow-acting antirheumatic drugs in juvenile rheumatoid arthritis. Arthritis Rheum 31: 15–20
Brewer EJ, Giannini EH, Kuzmina N, Alekseev L 1986 Penicillamine and hydroxychloroquine in the treatment of severe juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind placebo-controlled trial. N Eng J Med 314: 1269–1276
Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Wallin B 1990 Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group. Arthritis Rheum 33: 466–476
Giannini EH, Barron KS, Spencer CH, Person DA, Baum J, Bernstein BH, Kredich DW, Jacobs JC, Zemel LS, Gibbas D, Passo MH, Brewer EJ 1991 Auranofin therapy for juvenile rheumatoid arthritis: results of the five-year open-label extension trial. J Rheumatol 18: 1240–1242
Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS 1992 Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Eng J Med 326: 1043–1049
Silverman ED, Cawkwell GD, Lovell DJ, Laxer RM, Lehman TJ, Passo MH, Zemel LS, Giannini EH 1994 Intravenous immune globulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo-controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol 21: 2353–2358
Giannini EH, Lovell DJ, Silverman ED, Sundel RP, Tague BL, Ruperto N 1996 Intravenous immunoglobulin in the treatment of polyarticular juvenile rheumatoid arthritis. A phase I/II study. J Rheumatol 23: 919–924
Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore J, Finck B 2000 Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Eng J Med 342: 763–769
Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ 2003 Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48: 218–226
Lovell DJ, Lindsley C, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, Hicks JE, Levinson JE, Mier R, Pachman LM, Passo MH, Perez MD, Reed AM, Schikler KN, Smith M, Zemel LS, Rider LG 1999 Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 42: 2213–2219
Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A, Paediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG) 2003 Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 42: 1452–1459
Wallace CA, Ruperto N, Giannini E 2004 Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheum 11: 2290–2294
Rider LF, Pachman LM, Miller FW, Bollar H 2005 Myositis and Me: A Complete Family Guide to Juvenile Dermatomyositis and Other Inflammatory Myopathies. The Myositis Association, Washington, D.C.
Wedgwood RJ 1959 Diseases of mesenchymal tissues. In: Nelson WE (ed) Textbook of Pediatrics. WB Saunders, Philadelphia, pp 915–929
Ansell BM 1980 Rheumatic Disorders in Childhood. Butterworths & Co, London
Cassidy JT, Petty RE 2001 Textbook of Pediatric Rheumatology. Churchill Livingstone, New York
Jacobs JC 1993 Pediatric Rheumatology for the Practitioner. Springer-Verlag, New York
Schaller JG, Wedgwood RJ 1969 Is juvenile rheumatoid arthritis a single entity?. Pediatr Res 3: 370–371
Schaller J, Wedgwood RJ 1972 Juvenile rheumatoid arthritis: a review. Pediatrics 50: 940–953
Petty RE, Southwood TR, Baum J 1998 Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25: 1991–1994
Ramsey SE, Bolaria RK, Cabral DA, Malleson PN, Petty RE 2000 Comparison of criteria for the classification of childhood arthritis. J Rheumatol 27: 1283–1286
Schaller JG, Johnson GD, Holborow EJ, Ansell BM, Smiley WK 1974 The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). Arthritis Rheum 17: 409–416
Colbert RA 2004 The immunobiology of HLA-B27: variations on a theme. Curr Mol Med 4: 21–30
Patil NS, Pashine A, Belmares MP, Liu W, Kaneshiro B, Rabinowitz J, McConnell H, Mellins ED 2001 Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles. J Immunol 167: 7157–7168
Thompson SD, Moroldo MG, Guyer L, Ryan M, Tombragel EM, Shear ES, Prahalad S, Sudman M, Keddache MA, Brown WM, Giannini EH, Langefeld CD, Rich SS, Nichols WC, Glass DN 2004 A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. Arthritis Rheum 50: 2920–2930
Pascual V, Banchereau J, Palucka AK 2003 The central role of dendritic cells and interferon-alpha in SLE. Curr Opin Rheumatol 15: 548–556
Nepom GT, Nepom B 1998 Genetics of the major histocompatibility complex in rheumatoid arthritis. In: Klippel JH, Dieppe P (eds) Rheumatology. Mosby, London, pp 5.7.1–5.7.1.2
Rubin LA, Amos CI, Wade JA 1994 Investigating the genetic basis for ankylosing spondylitis. Arthritis Rheum 37: 1212–1220
Criswell LA, Amos CI 2000 Update on genetic risk factors for systemic lupus erythematosus and rheumatoid arthritis. Curr Opin Rheumatol 12: 85–90
Samuels J, Aksentijevich I, Torosyan Y 1998 Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine 77: 268–297
Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner D 2003 The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 15: 61–69
Khan MA 1995 HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 7: 263–269
Sakane T, Takeno M, Suzuki N, Inaba G 1999 Behcet's disease. N Engl J Med 341: 1284–1291
Melish ME, Hicks RM, Larson EJ 1976 Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 130: 599–607
Steere AC, Grodzicki RL, Kornblatt AN 1983 The spirochetal etiology of Lyme disease. N Engl J Med 308: 733–740
Nocton JJ, Miller LC, Tucker LB, Schaller JG 1993 Human parvovirus B19-associated arthritis in children. J Pediatr 122: 186–190
Dietzman DE, Schaller JG, Ray CG, Reed ME 1976 Acute myositis associated with influenza B infection. Pediatrics 57: 255–258
Schaller J 1972 Arthritis as a presenting manifestation of malignancy in children. J Pediatr 81: 793–796
Sherry DD, Wallace CA, Kelley C, Kidder M, Sapp L 1999 Short-and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy. Clin J Pain 15: 218–223
Buskila D, Neumann L, Hershman E, Gedalia A, Press J, Sukenik S 1995 Fibromyalgia syndrome in children—an outcome study. J Rheumatol 22: 525–528
Viner R, Gregorowski A, Wine C, Bladen M, Fisher D, Miller M, Neil EI 2004 Outpatient rehabilitative treatment of chronic fatigue syndrome (CFS/ME). Arch Dis Child 89: 615–619
Rose HM, Ragan C, Pearce E, Lipman MO 1948 Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 68: 1–6
Waaler E 1940 On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand 17: 172–188
Sack KE 2001 Evaluation of the patient: laboratory assessment. In: Klippel JH, Crofford LJ, Stone JH, Weyand CM (eds) Primer on the Rheumatic Diseases. Arthritis Foundation, Atlanta, pp 133–137
Frank M 1992 Detection of complement in relation to disease. Clin Immunol 89: 641–648
Schur PH, Austen KF 1972 Complement in the rheumatic diseases. Bull Rheum Dis 22: 666–673
Schaller JG, Gilliland GC, Ochs HD, Leddy JP, Agodoa LC, Rosenfeld SI 1977 Severe systemic lupus erythematosus with nephritis in a boy with deficiency of the fourth component of complement. Arthritis Rheum 20: 1519–1525
Ravelli A, Martini A 1997 Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin North Am 23: 657–677
Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH 2002 Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 35: 113–125
Veasy LG, Wiedmeier SE, Orsmond GS, Ruttenberg HD, Boucek MM, Roth SJ, Tait VF, Thompson JA, Daly JA, Kaplan EL, Hill HR 1987 Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 316: 421–427
Kaplan EL, Johnson DR, Cleary PP 1989 Group A streptococcal serotypes isolated from patients and sibling contacts during resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis 159: 101–103
Schaller JG, Ochs HD, Thomas ED, Nisperos B, Feigl P, Wedgwood RJ 1976 Histocompatibility antigens in childhood-onset arthritis. J Pediatr 88: 926–930
Schaller JG, Hansen J 1982 Rheumatoid factor-positive juvenile rheumatoid arthritis: the childhood equivalent of classic adult rheumatoid arthritis. Arthritis Rheum 25: S18
Williams RA, Ansell BM 1985 Radiological findings in seropositive juvenile chronic arthritis (juvenile rheumatoid arthritis) with particular reference to progression. Ann Rheum Dis 44: 685–693
Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ Jr, Fink CW, Hanson V, Jacobs JC, Masi AT, Schaller JG, Fries JF, McShane D, Young D 1986 A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 29: 274–281
Lehman TJ, Onel K 2000 Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136: 243–247
Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, Lee LA, Provost TT, Reichlin M, Rider L, Rupel A, Saleeb S, Weston WL, Skovron ML 1998 Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31: 1658–1666
Schaller J 1972 Illness resembling lupus erythematosus in mothers of boys with chronic granulomatous disease. Ann Intern Med 76: 747–750
Pachman LM 1995 Juvenile dermatomyositis. Pathophysiology and disease expression. Pediatr Clin North Am 42: 1071–1098
Pachman LM 1995 An update on juvenile dermatomyositis. Curr Opin Rheumatol 7: 437–441
Rider L, Miller F 2000 Idiopathic inflammatory muscle disease: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 14: 37–54
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association 2004 Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114: 1708–1733
Kato H, Koike S, Yamamoto M, Ito Y, Yano E 1975 Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr 86: 892–898
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R 1996 Long-term consequences of Kawasaki disease: a 10-to-21-year follow-up study of 594 patients. Circulation 94: 1379–1385
Meissner HC, Leung DY 2003 Kawasaki syndrome: where are the answers?. Pediatrics 112: 672–676
Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, Garcia-Consuegra J, Dolezalova P, Dressler F, Duzova A, Ferriani VP, Hilario MO, Ibanez-Rubio M, Kasapcopur O, Kuis W, Lehman TJ, Nemcova D, Nielsen S, Oliveira SK, Schikler K, Sztajnbok F, Terreri MT, Zulian F, Woo P 2004 Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr 145: 517–522
Kahaleh B 2004 Progress in research in systemic sclerosis. Lancet 364: 561–562
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schaller, J. The History of Pediatric Rheumatology. Pediatr Res 58, 997–1007 (2005). https://doi.org/10.1203/01.PDR.0000182823.85717.48
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/01.PDR.0000182823.85717.48
This article is cited by
-
Biological classification of childhood arthritis: roadmap to a molecular nomenclature
Nature Reviews Rheumatology (2021)
-
The Challenges and Opportunities of Classifying Childhood Arthritis
Current Rheumatology Reports (2020)
-
Optimizing treatment in paediatric rheumatology—lessons from oncology
Nature Reviews Rheumatology (2015)
-
Optimization of Pediatric Rheumatology Therapeutics
Clinical Pharmacology & Therapeutics (2012)
